Marco C. Miotto

Marco C. Miotto

Auto-generated profile, based on publicly available information

Marco C. Miotto

Columbia University Vagelos College of Physicians and Surgeons

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MMMarco C. Miotto
Marco C. Miotto
AVAriel A. Valiente-Gabioud
Ariel A. Valiente-Gabioud
GRGiulia Rossetti
Giulia Rossetti
MZMarkus Zweckstetter
Markus Zweckstetter
PCPaolo Carloni
Paolo Carloni
CFClaudio O. Fernandez
Claudio O. Fernandez

10 July 2023 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
HDHaikel Dridi
Haikel Dridi
YLYang Liu
Yang Liu
SRSteven Reiken
Steven Reiken
XLXiaoping Liu
Xiaoping Liu
EAElentina K. Argyrousi
Elentina K. Argyrousi
AMAndrew R. Marks
Andrew R. Marks
Cognitive dysfunction (CD) in heart failure (HF) adversely affects treatment compliance and quality of life. Although ryanodine receptor type 2 (RyR2) has been linked to cardiac muscle dysfunction, its role in CD in HF remains unclear. Here, we show in hippocampal neurons from individuals and mice with HF that the RyR2/intracellular Ca2+ release channels were subjected to post-translational modification (PTM) and were leaky. RyR2 PTM included protein kinase A phosphorylation, oxidation, nitrosylation and depletion of the stabilizing subunit calstabin2. RyR2 PTM was caused by hyper-adrenergic signaling and activation of the transforming growth factor-beta pathway. HF mice treated with a RyR2 stabilizer drug (S107), beta blocker (propranolol) or transforming growth factor-beta inhibitor (SD-208), or genetically engineered mice resistant to RyR2 Ca2+ leak (RyR2-p.Ser2808Ala), were protected against HF-induced CD. Taken together, we propose that HF is a systemic illness driven by intracellular Ca2+ leak that includes cardiogenic dementia.

11 April 2014 in Inorganic Chemistry
Verified
Journal Article
Closed access
MMMarco C. Miotto
Marco C. Miotto
EREsaú E. Rodriguez
Esaú E. Rodriguez
AVAriel A. Valiente-Gabioud
Ariel A. Valiente-Gabioud
VTValentina Torres-Monserrat
Valentina Torres-Monserrat
ABAndrés Binolfi
Andrés Binolfi
CFClaudio O. Fernandez
Claudio O. Fernandez

22 July 2022 in Science Advances
Verified
Journal Article
Open access
MMMarco C. Miotto
Marco C. Miotto
GWGunnar Weninger
Gunnar Weninger
HDHaikel Dridi
Haikel Dridi
QYQi Yuan
Qi Yuan
YLYang Liu
Yang Liu
AMAndrew R. Marks
Andrew R. Marks
Ryanodine receptor type 2 (RyR2) mutations have been linked to an inherited form of exercise-induced sudden cardiac death called catecholaminergic polymorphic ventricular tachycardia (CPVT). CPVT results from stress-induced sarcoplasmic reticular Ca 2+ leak via the mutant RyR2 channels during diastole. We present atomic models of human wild-type (WT) RyR2 and the CPVT mutant RyR2-R2474S determined by cryo–electron microscopy with overall resolutions in the range of 2.6 to 3.6 Å, and reaching local resolutions of 2.25 Å, unprecedented for RyR2 channels. Under nonactivating conditions, the RyR2-R2474S channel is in a “primed” state between the closed and open states of WT RyR2, rendering it more sensitive to activation that results in stress-induced Ca 2+ leak. The Rycal drug ARM210 binds to RyR2-R2474S, reverting the primed state toward the closed state. Together, these studies provide a mechanism for CPVT and for the therapeutic actions of ARM210.

19 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
HDHaikel Dridi
Haikel Dridi
Gaetano SantulliGaetano Santulli
Gaetano Santulli
LBLaith Bahlouli
Laith Bahlouli
MMMarco C. Miotto
Marco C. Miotto
GWGunnar Weninger
Gunnar Weninger
AMAndrew R. Marks
Andrew R. Marks
Heart failure is a serious global health challenge, affecting more than 6.2 million people in the United States and is projected to reach over 8 million by 2030. Independent of etiology, failing hearts share common features, including defective calcium (Ca2+) handling, mitochondrial Ca2+ overload, and oxidative stress. In cardiomyocytes, Ca2+ not only regulates excitation–contraction coupling, but also mitochondrial metabolism and oxidative stress signaling, thereby controlling the function and actual destiny of the cell. Understanding the mechanisms of mitochondrial Ca2+ uptake and the molecular pathways involved in the regulation of increased mitochondrial Ca2+ influx is an ongoing challenge in order to identify novel therapeutic targets to alleviate the burden of heart failure. In this review, we discuss the mechanisms underlying altered mitochondrial Ca2+ handling in heart failure and the potential therapeutic strategies.

1 May 2017 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
DCDaphne Cukierman
Daphne Cukierman
APAna Beatriz Pinheiro
Ana Beatriz Pinheiro
SCSergio L.P. Castiñeiras-Filho
Sergio L.P. Castiñeiras-Filho
ASAnastácia Sá P. da Silva
Anastácia Sá P. da Silva
MMMarco C. Miotto
Marco C. Miotto
NRNicolás A. Rey
Nicolás A. Rey